Literature DB >> 30995001

Cardiovascular Disease: Lower Extremity Deep Venous Thrombosis.

Michael Braun1, David Kassop2.   

Abstract

Risk factors for deep venous thrombosis (DVT) include immobility, recent or current hospitalization, recent surgery, recent infection, and cancer. Patients with suspected venous thromboembolism should be evaluated with the Wells score or modified Wells score (which adds a previous DVT) to determine the likelihood of DVT. A low or moderate probability score and a normal D-dimer test result exclude DVT. If the score indicates that DVT is likely, patients should undergo Doppler ultrasonography (US). If US reveals DVT in a proximal (ie, in the knee or above) vein, anticoagulation should be started unless contraindicated. If the DVT is distal (ie, below the knee), patients can be started on anticoagulation or monitored with repeat US and started on anticoagulation if the clot extends proximally. For anticoagulation, direct oral anticoagulants are recommended for most patients except pregnant women, for whom heparins are recommended. The treatment duration is at least 3 months, and longer if risk factors persist. Indefinite therapy may be required for patients with irreversible risk factors or inherited coagulation disorders. Other treatments, such as thrombectomy, thrombolytics, and vena cava filters, are used for select patients. Evaluation should include consideration of testing for occult cancer. Written permission from the American Academy of Family Physicians is required for reproduction of this material in whole or in part in any form or medium.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30995001

Source DB:  PubMed          Journal:  FP Essent        ISSN: 2159-3000


  2 in total

1.  Antithrombotic effect and action mechanism of Salvia miltiorrhiza and Panax notoginseng herbal pair on the zebrafish.

Authors:  Shi-Jun Yin; Ying-Qing Luo; Cong-Peng Zhao; Hua Chen; Zhang-Feng Zhong; Shengpeng Wang; Yi-Tao Wang; Feng-Qing Yang
Journal:  Chin Med       Date:  2020-04-16       Impact factor: 5.455

2.  Efficacy of modified pressure cuff for thrombolytic treatment on lower extremity deep venous thrombosis.

Authors:  Yan Li; Janesya Sutedjo; Yu-Chen Chen; Jian-Ping Gu
Journal:  Medicine (Baltimore)       Date:  2021-04-30       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.